Search

Your search keyword '"David K. Edwards"' showing total 61 results

Search Constraints

Start Over You searched for: Author "David K. Edwards" Remove constraint Author: "David K. Edwards"
61 results on '"David K. Edwards"'

Search Results

1. The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center

2. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

3. Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)

5. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells

6. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests

7. Estimating the Screening-Eligible Population Size, Ages 45–74, at Average Risk to Develop Colorectal Cancer in the United States

8. The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer

9. Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma

10. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma

11. Usability of an At-Home Anterior Nares SARS-CoV-2 RT-PCR Sample Collection Kit: Human Factors Feasibility Study (Preprint)

12. Usability of an At-Home Anterior Nares SARS-CoV-2 RT-PCR Sample Collection Kit: Human Factors Feasibility Study

13. Functional genomic landscape of acute myeloid leukaemia

14. Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples

15. Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

16. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma

17. Recurrent cyclin D2 mutations in myeloid neoplasms

18. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

19. Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells

20. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells

22. Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)

23. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

24. RNAi screening of the tyrosine kinome in primary patient samples of acute myeloid leukemia

26. Abstract 1087: CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD

27. Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation

28. Cytokine-Mediated Inflammatory Pathways Promote Clonal Evolution and Disease Progression in Acute Myeloid Leukemia

29. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer

30. CSF1R Inhibition Targets AML Cells By Depleting Supportive Microenvironmental Signal from CD14+ Monocytes

31. The Pro-Inflammatory Cytokine Interleukin-1 Is Essential for Clonal Expansion and Disease Progression in Acute Myeloid Leukemia

32. p38MAPK Inhibition Blocks Inflammatory Signaling in Acute Myeloid Leukemia

33. Targeted Suppression of Interleukin-1 Signaling Attenuates Leukemic Cellular Growth and Disease Progression in Primary Human Cells and Murine Models of Acute Myeloid leukemia­­

34. Abstract 5209: Characterization of an isogenic model system for KDM6A/UTX loss in multiple myeloma

35. Extensive Genetic Characterization of MM.1R and MM.1S Identifies Several Events Contributing to Dexamethasone Resistance

36. The Comprehensive Genomic Characterization of All Commercially Available Multiple Myeloma Cell Lines

37. Abstract 3048: microRNA biomarkers associated with sunitinib-resistance in non-small cell lung cancer

38. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

40. Reduction of Lung Injury by Human Surfactant Treatment in Respiratory Distress Syndrome

41. The contribution of PDA in the neonate with severe RDS

42. Patent ductus arteriosus treated with ligation orindomethacin: A follow-up study

43. The Hemodynamic Significance of Massive Pneumopericardium in Preterm Infants with Respiratory Distress Syndrome

44. Twelve Years' Experience With Bronchopulmonary Dysplasia

45. Radiographic aspects of bronchopulmonary dysplasia

46. Minimizing bronchopulmonary dysplasia in VLBW infants

47. Radiographic-pathologic correlation in bronchopulmonary dysplasia

48. Vascular pathogenesis of unilateral craniofacial defects

49. Prophylactic treatment of very premature infants with human surfactant

Catalog

Books, media, physical & digital resources